arginine vasopressin has been researched along with Alzheimer Disease in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (41.18) | 18.7374 |
| 1990's | 13 (38.24) | 18.2507 |
| 2000's | 4 (11.76) | 29.6817 |
| 2010's | 2 (5.88) | 24.3611 |
| 2020's | 1 (2.94) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Y; Guo, J; Qi, J; Wang, C; Wang, Z; Wu, M; Yang, W; Zhang, J; Zhang, X; Zhao, F; Zhou, F | 1 |
| Cheng, L; Guo, F; Jing, W; Qi, JS; Zhang, JF | 1 |
| Hofman, MA; Hoogendijk, WJ; Meynen, G; Swaab, DF; Unmehopa, UA | 1 |
| Bao, AM; Swaab, DF | 1 |
| Hut, RA; Van der Zee, EA | 1 |
| Collins, GB; Marzewski, DJ; Rollins, MB | 1 |
| Fujiyoshi, K; Iijima, S; Kato, T; Koshimura, K; Miyata, S; Nagata, H; Nakamura, S; Okamoto, K; Suga, H; Yamao, S | 1 |
| Coughlan, AK; Jenkins, JS; Mather, HM | 1 |
| Gonatas, NK; Lucassen, PJ; Pool, CW; Salehi, A; Swaab, DF | 1 |
| Raadsheer, FC; Swaab, DF; Tilders, FJ | 1 |
| Gonatas, NK; Lucassen, PJ; Ravid, R; Swaab, DF | 1 |
| Bodenheimer, S; Dorsa, DM; Pascualy, M; Peskind, ER; Raskind, MA; Thal, L; Veith, RC; Wingerson, D | 1 |
| Fujiwara, T; Iwamoto, Y; Kato, T; Okamiya, K; Shinoda, M; Toide, K | 1 |
| Dobie, DJ; Edland, SD; Pascualy, M; Peskind, ER; Raskind, MA; Wingerson, D | 1 |
| Hofman, MA; Hoogendijk, WJ; Lucassen, PJ; Mirmiran, M; Swaab, DF; van Someren, EJ; Zhou, JN | 1 |
| Growdon, JH; Kim, C; Nitsch, RM | 1 |
| Cairns, N; Fang-Kircher, S; Labudova, O; Lubec, G; Moenkemann, H; Yeghiazaryan, K | 1 |
| Hofman, MA; Hoogendijk, WJ; Kamphorst, W; Liu, RY; Swaab, DF; Unmehopa, UA; van Heerikhuize, J; Zhou, JN | 1 |
| Ishunina, TA; Swaab, DF | 1 |
| Stern, GM | 1 |
| Fairbairn, AF; Ferrier, IN; Jabeen, S; Leake, A; McKeith, IG; Perry, EK; Perry, RH | 1 |
| Nakamura, S | 1 |
| Lowenthal, A; Riekkinen, P; Sennef, C; Van der Plaats, JJ; Wolters, EC; Zwart, JM | 1 |
| Helkala, EL; Jolkkonen, J; Kutvonen, R; Lehtinen, M; Riekkinen, PJ | 1 |
| Borson, S; Dorsa, DM; Gumbrecht, G; Lampe, TH; Peskind, ER; Raskind, MA; Risse, SC; Veith, RC | 1 |
| Dorsa, D; Lampe, TH; Peskind, ER; Raskind, MA; Risse, SC; Taborsky, GJ | 1 |
| Beal, MF; Martin, JB; Mazurek, MF | 1 |
| Bertora, P; Bevilacqua, M; Carella, F; Chebat, E; Grassi, MP; Mangoni, A; Norbiato, G; Raggi, U | 1 |
| Fisser, B; Kamphorst, W; Swaab, DF; Troost, D | 1 |
| Fujiyoshi, K; Kameyama, M; Nakamura, S; Okamoto, K; Suga, H | 1 |
| Beal, MF; Bird, ED; Martin, JB; Mazurek, MF | 1 |
| Berger, PA; Miller, TP; Peabody, CA; Pigache, R; Thiemann, S; Tinklenberg, JR; Yesavage, J | 1 |
| Fliers, E; Partiman, TS; Swaab, DF | 1 |
| Fliers, E; Pool, CW; Swaab, DF; Verwer, RW | 1 |
7 review(s) available for arginine vasopressin and Alzheimer Disease
| Article | Year |
|---|---|
Corticotropin-releasing hormone and arginine vasopressin in depression focus on the human postmortem hypothalamus.
Topics: Alzheimer Disease; Animals; Arginine Vasopressin; Corticotropin-Releasing Hormone; Depressive Disorder; Female; Humans; Hypothalamo-Hypophyseal System; Hypothalamus; Male; Pituitary-Adrenal System; Postmortem Changes; Sex Characteristics; Sex Factors; Stress, Psychological | 2010 |
The cholinergic system, circadian rhythmicity, and time memory.
Topics: Acetylcholine; Aging; Alzheimer Disease; Animals; Arginine Vasopressin; Brain; Cholinergic Fibers; Circadian Clocks; Circadian Rhythm; Humans; Memory; Models, Biological; Receptors, Muscarinic; Suprachiasmatic Nucleus; Synaptic Transmission | 2011 |
Neurohypophyseal peptides in aging and Alzheimer's disease.
Topics: Aging; Alzheimer Disease; Animals; Arginine Vasopressin; Humans; Oxytocin; Paraventricular Hypothalamic Nucleus; Pituitary Hormones, Posterior; Supraoptic Nucleus | 2002 |
New drug interventions in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Arginine Vasopressin; Cholinesterase Inhibitors; G(M1) Ganglioside; Humans; Mental Recall; Neuropsychological Tests; Physostigmine; Pilot Projects; Receptors, Cholinergic; Tacrine | 1992 |
Senile dementia and presenile dementia.
Topics: Acetylcholinesterase; Alzheimer Disease; Arginine Vasopressin; Biopterins; Brain Chemistry; Cerebral Cortex; Choline O-Acetyltransferase; Cross-Sectional Studies; Dementia; Dopamine beta-Hydroxylase; Glutamate Decarboxylase; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Japan; Neurotransmitter Agents | 1990 |
Neuropeptides in Alzheimer's disease. Clinical implications.
Topics: Adrenocorticotropic Hormone; Alzheimer Disease; Arginine Vasopressin; Brain; Endorphins; Humans; Memory; Neuropeptides; Oxytocin | 1986 |
The human suprachiasmatic nucleus; neuropeptide changes in senium and Alzheimer's disease.
Topics: Adult; Aging; Alzheimer Disease; Animals; Arginine Vasopressin; Circadian Rhythm; Female; Humans; Male; Middle Aged; Neuropeptides; Prader-Willi Syndrome; Rats; Reproduction; Suprachiasmatic Nucleus; Transsexualism | 1988 |
2 trial(s) available for arginine vasopressin and Alzheimer Disease
| Article | Year |
|---|---|
DGAVP (Org 5667) in early Alzheimer's disease patients: an international double-blind, placebo-controlled, multicenter trial.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Arginine Vasopressin; Chi-Square Distribution; Double-Blind Method; Humans; Middle Aged; Multicenter Studies as Topic; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic | 1990 |
Desglycinamide-9-arginine-8-vasopressin (DGAVP, Organon 5667) in patients with dementia.
Topics: Affect; Aged; Alcoholism; Alzheimer Disease; Arginine Vasopressin; Clinical Trials as Topic; Dementia; Humans; Learning; Mental Recall; Middle Aged | 1985 |
25 other study(ies) available for arginine vasopressin and Alzheimer Disease
| Article | Year |
|---|---|
AVP(4-8) Improves Cognitive Behaviors and Hippocampal Synaptic Plasticity in the APP/PS1 Mouse Model of Alzheimer's Disease.
Topics: Alzheimer Disease; Animals; Arginine Vasopressin; Disease Models, Animal; Hippocampus; Long-Term Potentiation; Male; Maze Learning; Memory Disorders; Mice; Mice, Transgenic; Neuroprotective Agents; Peptide Fragments | 2020 |
Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Arginine Vasopressin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Excitatory Postsynaptic Potentials; Hippocampus; Injections, Intraventricular; Long-Term Potentiation; Male; Memory Disorders; Nootropic Agents; Peptide Fragments; Rats; Rats, Wistar; Synaptic Transmission; Time Factors | 2009 |
Hypothalamic vasopressin and oxytocin mRNA expression in relation to depressive state in Alzheimer's disease: a difference with major depressive disorder.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Arginine Vasopressin; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Hypothalamus; Male; Neurons; Oxytocin; Prospective Studies; RNA, Messenger | 2009 |
Paranoid psychosis after DDAVP therapy for Alzheimer's dementia.
Topics: Alzheimer Disease; Arginine Vasopressin; Deamino Arginine Vasopressin; Dementia; Diagnosis, Differential; Female; Humans; Middle Aged; Paranoid Disorders | 1981 |
Neurotransmitters in dementia.
Topics: Adult; Aged; Alzheimer Disease; Arginine Vasopressin; Biopterins; Central Nervous System; Cerebral Cortex; Choline O-Acetyltransferase; Dementia; Dopamine beta-Hydroxylase; Homovanillic Acid; Humans; Middle Aged; Neurotransmitter Agents; Reference Values; Substantia Innominata | 1984 |
Effect of desmopressin on normal and impaired memory.
Topics: Adult; Aged; Alcohol Amnestic Disorder; Alzheimer Disease; Arginine Vasopressin; Deamino Arginine Vasopressin; Dementia; Double-Blind Method; Female; Humans; Male; Memory; Mental Recall; Middle Aged | 1982 |
Activation of vasopressin neurons in aging and Alzheimer's disease.
Topics: Adult; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Arginine Vasopressin; Golgi Apparatus; Humans; Immunohistochemistry; Microscopy, Immunoelectron; Middle Aged; Neurons; Oxytocin; Paraventricular Hypothalamic Nucleus; Supraoptic Nucleus | 1994 |
Similar age related increase of vasopressin colocalization in paraventricular corticotropin-releasing hormone neurons in controls and Alzheimer patients.
Topics: Adult; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Arginine Vasopressin; Corticotropin-Releasing Hormone; Humans; Immunohistochemistry; Middle Aged; Neurons; Paraventricular Hypothalamic Nucleus; RNA, Messenger | 1994 |
Activation of the human supraoptic and paraventricular nucleus neurons with aging and in Alzheimer's disease as judged from increasing size of the Golgi apparatus.
Topics: Adult; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Arginine Vasopressin; Female; Golgi Apparatus; Humans; Immunohistochemistry; Male; Middle Aged; Neurons; Paraventricular Hypothalamic Nucleus; Receptors, Cell Surface; Receptors, Fibroblast Growth Factor; Sialoglycoproteins; Supraoptic Nucleus | 1993 |
Oral physostigmine in Alzheimer's disease: effects on norepinephrine and vasopressin in cerebrospinal fluid and plasma.
Topics: Administration, Oral; Aged; Alzheimer Disease; Arginine Vasopressin; Cholinesterase Inhibitors; Delayed-Action Preparations; Female; Humans; Male; Norepinephrine; Physostigmine; Water-Electrolyte Balance | 1995 |
Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on neuropeptide metabolism in the rat brain.
Topics: Administration, Oral; Alzheimer Disease; Animals; Arginine Vasopressin; Cerebral Cortex; Dose-Response Relationship, Drug; Hippocampus; Neuropeptides; Prolyl Oligopeptidases; Pyrrolidines; Rats; Rats, Wistar; Serine Endopeptidases; Serine Proteinase Inhibitors; Substance P; Thyrotropin-Releasing Hormone | 1996 |
Plasma arginine vasopressin response to hypertonic saline infusion in Alzheimer disease.
Topics: Aged; Alzheimer Disease; Arginine Vasopressin; Blood Pressure; Humans; Infusions, Intravenous; Middle Aged; Osmolar Concentration; Sodium Chloride; Time Factors | 1995 |
Circadian rhythm-related behavioral disturbances and structural hypothalamic changes in Alzheimer's disease.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Arginine Vasopressin; Brain Mapping; Circadian Rhythm; Female; Humans; Hypothalamic Diseases; Hypothalamus; Male; Middle Aged; Sleep Stages; Social Behavior Disorders; Suprachiasmatic Nucleus; Vasoactive Intestinal Peptide; Wakefulness | 1996 |
Vasopressin and bradykinin regulate secretory processing of the amyloid protein precursor of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Arginine Vasopressin; Bradykinin; Cell Line; Endopeptidases; GTP-Binding Proteins; Inositol; Inositol Phosphates; Kidney; Kinetics; Neuropeptides; PC12 Cells; Phosphatidylinositols; Protein Kinase C; Protein Processing, Post-Translational; Rats; Receptors, Bradykinin; Receptors, Vasopressin; Signal Transduction | 1998 |
Brain vasopressin levels in Down syndrome and Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amino Acid Sequence; Arginine Vasopressin; Base Sequence; Brain; Down Syndrome; Female; Fetus; Humans; Male; Molecular Sequence Data; Nucleic Acid Hybridization; Tissue Distribution | 1998 |
Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Arginine Vasopressin; Circadian Rhythm; Depression; Female; Gene Expression; Humans; In Situ Hybridization; Male; Middle Aged; RNA, Messenger; Severity of Illness Index; Suprachiasmatic Nucleus | 2000 |
Neocortical concentrations of neuropeptides in senile dementia of the Alzheimer and Lewy body type: comparison with Parkinson's disease and severity correlations.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Arginine Vasopressin; Cerebral Cortex; Corticotropin-Releasing Hormone; Dementia; Female; Humans; Inclusion Bodies; Male; Neurofibrils; Neuropeptides; Neuropsychological Tests; Occipital Lobe; Parkinson Disease; Somatostatin; Temporal Lobe | 1991 |
Vasopressin levels in CSF of Alzheimer patients: correlations with monoamine metabolites and neuropsychological test performance.
Topics: Aged; Alzheimer Disease; Arginine Vasopressin; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Mental Recall; Methoxyhydroxyphenylglycol; Middle Aged; Neuropsychological Tests | 1989 |
Neuroendocrine responses to physostigmine in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Arginine Vasopressin; beta-Endorphin; Blood Pressure; Brain; Epinephrine; Humans; Infusions, Intravenous; Male; Parasympathetic Nervous System; Physostigmine | 1989 |
Cerebrospinal fluid vasopressin, oxytocin, somatostatin, and beta-endorphin in Alzheimer's disease.
Topics: Adult; Age Factors; Aged; Alzheimer Disease; Arginine Vasopressin; beta-Endorphin; Endorphins; Female; Humans; Male; Osmolar Concentration; Oxytocin; Somatostatin; Vasopressins | 1986 |
Alterations in vasopressin regulation in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Arginine Vasopressin; Blood Pressure; Female; Humans; Hypothalamus; Male; Metoclopramide; Middle Aged; Nitroprusside; Pressoreceptors; Water-Electrolyte Balance | 1988 |
Reduction of arginine-vasopressin in the cerebral cortex in Alzheimer type senile dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Arginine Vasopressin; Cerebral Cortex; Female; Humans; Male | 1987 |
Vasopressin in Alzheimer's disease: a study of postmortem brain concentrations.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Arginine Vasopressin; Brain Chemistry; Female; Humans; In Vitro Techniques; Male; Middle Aged; Postmortem Changes; Radioimmunoassay | 1986 |
The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia.
Topics: Adolescent; Adult; Age Factors; Aged; Alzheimer Disease; Arginine Vasopressin; Brain Chemistry; Child; Female; Histocytochemistry; Humans; Immunochemistry; Male; Middle Aged; Sex Factors; Suprachiasmatic Nucleus | 1985 |
The vasopressin and oxytocin neurons in the human supraoptic and paraventricular nucleus; changes with aging and in senile dementia.
Topics: Adolescent; Adult; Aged; Aging; Alzheimer Disease; Arginine Vasopressin; Child; Female; Histocytochemistry; Humans; Immunochemistry; Male; Middle Aged; Neurons; Oxytocin; Paraventricular Hypothalamic Nucleus; Supraoptic Nucleus | 1985 |